Centenary Institute hosts TB research symposium
2 June, 2025 
Tuberculosis (TB) is a serious infectious disease that claims the lives of approximately 1.25 million people globally each year.
The symposium focused on efforts tackling TB across Australia and the Indo-Pacific region, providing a valuable platform for researchers to collaborate, share the latest scientific insights and shape the future of TB research.
Presentations covered key themes including TB detection in Asia and the Pacific, new tools for TB diagnosis and modelling, the latest developments in TB prevention, community engagement strategies and TB control efforts in Australia.
Among the speakers was the Centenary Institute’s Dr Jeremy Hill, a TB clinician and medical lead of the PEARL (Pathway to the Elimination of Antibiotic Resistant and Latent Tuberculosis in the Pacific) program in Kiribati. Dr Hill provided an update on the program, which focuses on community-based screening and treatment for both TB and leprosy.
The TB-CRE, funded by the National Health and Medical Research Council, is committed to world-class research aimed at detecting, preventing and treating tuberculosis in Australia and globally. The Centenary Institute is proud to be an affiliate of the TB-CRE.
